Salix Among RMTC Board Meeting’s Topics
The Blood-Horse Staff
October 11, 2011
Race day medications, drug testing initiatives, and research committees were discussed at an Oct. 6 meeting.
Race day medications, drug testing initiatives, and research committees were discussed at an Oct. 6 meeting.
Thoroughbred horsemen’s groups are drawing a line in the sand when it comes to the anti-bleeding drug Salix.
A KHRC advisory panel approved a recommendation to prohibit the race day use of adjunct bleeder medications.
The Jockey Club reiterated its calls for a ban of Salix but made it clear it wants medication-free racing.
BloodHorse.com’s Jason Shandler caught up with Mike Repole to get his opinion on the current Salix debate.
The AGSC will employ a program banning race-day medications in graded 2-year-old Thoroughbred stakes races.
The RMTC will continue to study a pilot program proposal to ban the use of Salix in 2-year-old Thoroughbreds.
The National Horsemen’s Benevolent and Protective Association supports elimination of race-day medications
A baby step toward progress was how organizers described the two-day International Race Day Medication Summit
Concerns about Salix’s performance-enhancing attributes may pale in comparison to the potential detrimental
Anyone hoping to learn the intricacies of Salix use, research, and regulation at the June 13 International
Exercise-induced pulmonary hemorrhaging discussed on Day 1 of the International Summit on Race Day Medication
Another battle over the medication Salix is brewing. We say “another” because Thoroughbred racing has been
The “International Summit on Race Day Medication, EIPH, and the Racehorse” will begin June 13 at Belmont Park.
The “International Summit on Race Day Medication, Exercised-Induced Pulmonary Hemorrhage (EIPH), and the Racehorse” has been scheduled for June 13-14 in New York City. The event is jointly sponsored by the American Association of Equine Practitioners
The board of directors of the Association of Racing Commissioners International (RCI) voted without objection this week in favor of a resolution calling for the re-examination of whether its current policy pertaining to furosemide (Salix, commonly
Stay on top of the most recent Horse Health news with
